The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation

[1]  Xianlong Zhou,et al.  The role of inflammation in postresuscitation myocardial dysfunction. , 2013, International Journal of Cardiology.

[2]  R. Neumar,et al.  Post–Cardiac Arrest Syndrome Epidemiology, Pathophysiology, Treatment, and Prognostication A Consensus Statement From the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Strok , 2008 .

[3]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[4]  S. Nasoohi,et al.  MCC950, the selective NLRP3 inflammasome inhibitor protects mice against traumatic brain injury , 2018 .

[5]  C. Ince,et al.  Comparison of Different Methods for the Calculation of the Microvascular Flow Index , 2012, Critical care research and practice.

[6]  B. V. Van Tassell,et al.  Targeting interleukin-1 in heart disease. , 2013, Circulation.

[7]  S. Carbone,et al.  Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse. , 2016, International journal of cardiology.

[8]  Haitao Wen,et al.  Mechanisms of NOD-like receptor-associated inflammasome activation. , 2013, Immunity.

[9]  M. Weil,et al.  Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. , 1988, Circulation.

[10]  K. Schroder,et al.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.

[11]  S. Nasoohi,et al.  Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke , 2018, Scientific Reports.

[12]  G. Ospina-Tascón,et al.  How to evaluate the microcirculation: report of a round table conference , 2007, Critical care.

[13]  Y. Leng,et al.  NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats , 2017, Oxidative medicine and cellular longevity.

[14]  C. Day,et al.  MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition , 2019, Nature Chemical Biology.

[15]  S. Nasoohi,et al.  MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury. , 2018, Journal of neurotrauma.

[16]  B. Böttiger,et al.  [Post-resuscitation syndrome. Role of inflammation after cardiac arrest]. , 2012, Der Anaesthesist.

[17]  Wanchun Tang,et al.  Comparison of the Durations of Mild Therapeutic Hypothermia on Outcome After Cardiopulmonary Resuscitation in the Rat , 2012, Circulation.

[18]  Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men. , 2004 .

[19]  M. Weil,et al.  The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. , 2001, Journal of the American College of Cardiology.

[20]  A. Abbate,et al.  Role of NLRP3 (cryopyrin) in acute myocardial infarction. , 2013, Cardiovascular research.

[21]  A. Abbate,et al.  The NLRP3 inflammasome in acute myocardial infarction , 2018, Nature Reviews Cardiology.

[22]  L. Ekström,et al.  Hospital mortality after out-of-hospital cardiac arrest among patients found in ventricular fibrillation. , 1995, Resuscitation.

[23]  G. Pasterkamp,et al.  The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction , 2016, European heart journal.

[24]  P. Safar,et al.  Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. , 1984, Resuscitation.

[25]  Y. Arbel,et al.  A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today? , 2018, Cardiology and Therapy.

[26]  Wanchun Tang,et al.  Delta-opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction. , 2004, American journal of physiology. Heart and circulatory physiology.

[27]  Anindita Das,et al.  Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse , 2015, Journal of cardiovascular pharmacology.

[28]  J. Nolan,et al.  Mode of death after admission to an intensive care unit following cardiac arrest , 2004, Intensive Care Medicine.

[29]  Q. Guo,et al.  Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-ɤ , 2018, Cellular Physiology and Biochemistry.

[30]  Robert A. Berg,et al.  International Consensus on Cardiopulmonary Resuscitation and mergency Cardiovascular Care Science with Treatment ecommendations , 2015 .

[31]  L. Becker,et al.  Abstract 280: Evaluation of Cerebral Blood Oxygenation by NIRS During Asphyxia Cardiac Arrest and Resuscitation in Rats , 2019, Circulation.

[32]  J. Ornato,et al.  Effects of Polyethylene Glycol-20k on Postresuscitation Myocardial and Cerebral Function in a Rat Model of Cardiopulmonary Resuscitation , 2018, Critical care medicine.

[33]  M. Weil,et al.  Progressive myocardial dysfunction after cardiac resuscitation , 1993, Critical care medicine.

[34]  M. Hazinski,et al.  2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. , 2020, Pediatrics.

[35]  Li Yao,et al.  MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice. , 2020, Bioorganic & medicinal chemistry.